All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Search results for “type 2 diabetes ”
Show results per page.
Showing 1–17 of 17 results.
Type 2 Diabetes Mellitus Treatment Guidance
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/type-2-diabetes-mellitus-treatment-guidance Management of hypertension
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/hypertension 6.1.2 Antidiabetic drugs
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-2-antidiabetic-drugs 6.1.6 Diagnostic and monitoring devices for diabetes mellitus
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-6-diagnostic-and-monitoring-devices-for-diabetes-mellitus 6.5.2 Posterior pituitary hormones and antagonists
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6.5-hypothalamic-and-pituitary-hormones-and-anti-oestrogens/6-5-2-posterior-pituitary-hormones-and-antagonists 2.12 Lipid regulating drugs
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-12-lipid-regulating-drugs 2.5.5 Drugs affecting the renin-angiotensin system
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-5-hypertension-and-heart-failure/2-5-5-drugs-affecting-the-renin-angiotensin-system 1.9.2 Bile acid sequestrants
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/1-gastrointestinal/1-9-intestinal-secretions/1-9-2-bile-acid-sequestrants 2.2.3 Potassium-sparing diuretics and aldosterone antagonists
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-2-diuretics/2-2-3-potassium-sparing-and-aldosterone-antagonists 13.2.1 Emollients
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/13-skin/13-2-emollient-and-barrier-preparations/13-2-1-emollients 10.1.3 Drugs that suppress the rheumatic disease process
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-3-drugs-suppress-rheumatic-disease 6.1.7 Continuous Glucose Monitors (CGM)
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-7-continuous-glucose-monitors-cgm 6.1.1 Insulins
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-1-insulins 4.5 Drugs used in the treatment of obesity
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-5-drugs-used-in-the-treatment-of-obesity Recent Formulary Updates
https://southwest.devonformularyguidance.nhs.uk/formulary/formulary-updates/recent-updates Psoriasis management
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/13-skin/psoriasis Management of neuropathic pain
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/neuropathic-pain
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/type-2-diabetes-mellitus-treatment-guidance Management of hypertension
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/hypertension 6.1.2 Antidiabetic drugs
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-2-antidiabetic-drugs 6.1.6 Diagnostic and monitoring devices for diabetes mellitus
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-6-diagnostic-and-monitoring-devices-for-diabetes-mellitus 6.5.2 Posterior pituitary hormones and antagonists
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6.5-hypothalamic-and-pituitary-hormones-and-anti-oestrogens/6-5-2-posterior-pituitary-hormones-and-antagonists 2.12 Lipid regulating drugs
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-12-lipid-regulating-drugs 2.5.5 Drugs affecting the renin-angiotensin system
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-5-hypertension-and-heart-failure/2-5-5-drugs-affecting-the-renin-angiotensin-system 1.9.2 Bile acid sequestrants
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/1-gastrointestinal/1-9-intestinal-secretions/1-9-2-bile-acid-sequestrants 2.2.3 Potassium-sparing diuretics and aldosterone antagonists
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-2-diuretics/2-2-3-potassium-sparing-and-aldosterone-antagonists 13.2.1 Emollients
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/13-skin/13-2-emollient-and-barrier-preparations/13-2-1-emollients 10.1.3 Drugs that suppress the rheumatic disease process
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-3-drugs-suppress-rheumatic-disease 6.1.7 Continuous Glucose Monitors (CGM)
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-7-continuous-glucose-monitors-cgm 6.1.1 Insulins
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-1-insulins 4.5 Drugs used in the treatment of obesity
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-5-drugs-used-in-the-treatment-of-obesity Recent Formulary Updates
https://southwest.devonformularyguidance.nhs.uk/formulary/formulary-updates/recent-updates Psoriasis management
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/13-skin/psoriasis Management of neuropathic pain
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/neuropathic-pain
